To confirm HeyA8 results, MDA-MB-231 and MCF-7 breast cancer cell lines showed similar increase in CXCR4 surface expression after treatment with MEK inhibitor U0126 and 3D spheroids as compared to adherent (Fig. 4C). The gene discussed is CXCR4; the disease is breast carcinoma.